Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.44 |
| ▸ | ATM | Q13315 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22639426 | 0.99 | ATM (0.42) | L3MBTL1ATMKDM4EKMT2AMAPT | |
| SCHEMBL23319005 | 0.95 | L3MBTL1 (0.44) | L3MBTL1ATMKDM4EKMT2AMAPT | |
| SCHEMBL22639431 | 0.93 | KDM4E (0.38) | L3MBTL1ATMKDM4EKMT2AMAPT | |
| SCHEMBL22639390 | 0.93 | KDM4E (0.40) | L3MBTL1ATMKDM4EKMT2AMAPT | |
| SCHEMBL22639382 | 0.92 | ATM (0.39) | L3MBTL1ATMKDM4EKMT2AMAPT | |
| SCHEMBL25679966 | 0.91 | ATM (0.41) | L3MBTL1ATMKDM4EKMT2AMAPT | |
| SCHEMBL22639425 | 0.91 | KDM4E (0.38) | L3MBTL1ATMKDM4EKMT2AMAPT | |
| SCHEMBL24787784 | 0.89 | KDM4E (0.39) | L3MBTL1ATMKDM4EKMT2AMAPT | |
| SCHEMBL24824200 | 0.89 | KDM4E (0.36) | L3MBTL1ATMKDM4EKMT2AMAPT | |
| SCHEMBL20405005 | 0.88 | KDM4E (0.38) | L3MBTL1ATMKDM4EKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220416171-A1 | ORGANIC ELECTROLUMINESCENT DEVICE CONFIGURED TO EMIT LIGHT WITH HIGH LUMINOUS EFFICIENCY | IDEMITSU KOSAN CO.,LTD. (JP) | 2022-12-29 | — | — | US | disclosed |
| US-20220173334-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS EQUIPPED WITH THE SAME | IDEMITSU KOSAN CO.,LTD. (JP) | 2022-06-02 | — | — | US | disclosed |
| US-20220165964-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | IDEMITSU KOSAN CO.,LTD. (JP) | 2022-05-26 | — | — | US | disclosed |
| EP-3372593-B1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEMICAL LTD (KR) | 2020-12-23 | — | — | EP | disclosed |
| US-10833278-B2 | Compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2020-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10833278-B2 | Compound and organic light emitting device comprising the same | CRY1, CRY2, ORC3 | L3MBTL1 1353/4885ATM 2733/4885KDM4E 2260/4885 |
| US-20220165964-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | LEF1, OR10J3, RER1 | L3MBTL1 691/4885ATM 3029/4885KDM4E 2867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.